Correction to:: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)

D T P Buis; T W van der Vaart; J M Prins; J T M van der Meer; M J M Bonten; E Sieswerda; C H van Werkhoven; K C E Sigaloff

doi:10.1093/jac/dkad385

Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)

D T P Buis^*
, T W van der Vaart
, J M Prins
, J T M van der Meer
, M J M Bonten
, E Sieswerda
, C H van Werkhoven
, K C E Sigaloff

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

6 Downloads (Pure)

Abstract

To our regret we realized that the following error was present in multivariable analyses, neither cefuroxime nor ceftriaxone was the original published version of this article: In the Abstract, associated with increased duration of bacteraemia compared Results section: “In multivariable analyses, neither ceftriaxone with flucloxacillin (HR 1.08, 95% CI 0.73–1.60 and HR 1.22, 95% nor cefuroxime was associated with increased duration of CI 0.88–1.71)”. bacteraemia compared with flucloxacillin (HR 1.08, 95% CI The overall conclusions of the study remain unaltered. 0.73–1.60 and HR 1.22, 95% CI 0.88–1.71)” should read “In We apologize for the inconvenience.

Original language	English
Article number	dkad385
Pages (from-to)	476
Number of pages	1
Journal	The Journal of antimicrobial chemotherapy
Volume	79
Issue number	2
Early online date	11 Dec 2023
DOIs	https://doi.org/10.1093/jac/dkad385
Publication status	Published - 1 Feb 2024

Access to Document

10.1093/jac/dkad385Licence: CC BY-NC

dkad385Final published version, 118 KBLicence: CC BY-NC

Fingerprint

Dive into the research topics of 'Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)'. Together they form a unique fingerprint.

1 Article

Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study
Buis, D. T. P., van der Vaart, T. W., Prins, J. M., van der Meer, J. T. M., Bonten, M. J. M., Sieswerda, E., van Werkhoven, C. H., Sigaloff, K. C. E., Herpers, B. L., Jansen, R. R., Rozemeijer, W., Soetekouw, R., van Twillert, G. & Veenstra, J., 3 May 2023, In: The Journal of antimicrobial chemotherapy. 78, 5, p. 1175-1181 7 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File
5 Downloads (Pure)

Cite this

Buis, D. T. P., van der Vaart, T. W., Prins, J. M., van der Meer, J. T. M., Bonten, M. J. M., Sieswerda, E., van Werkhoven, C. H., & Sigaloff, K. C. E. (2024). Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057). The Journal of antimicrobial chemotherapy, 79(2), 476. Article dkad385. https://doi.org/10.1093/jac/dkad385

@article{931ef45aa5bd4b9ab60876a11ec01c39,

title = "Correction to:: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)",

abstract = "To our regret we realized that the following error was present in multivariable analyses, neither cefuroxime nor ceftriaxone was the original published version of this article: In the Abstract, associated with increased duration of bacteraemia compared Results section: “In multivariable analyses, neither ceftriaxone with flucloxacillin (HR 1.08, 95\% CI 0.73–1.60 and HR 1.22, 95\% nor cefuroxime was associated with increased duration of CI 0.88–1.71)”. bacteraemia compared with flucloxacillin (HR 1.08, 95\% CI The overall conclusions of the study remain unaltered. 0.73–1.60 and HR 1.22, 95\% CI 0.88–1.71)” should read “In We apologize for the inconvenience.",

author = "Buis, \{D T P\} and \{van der Vaart\}, \{T W\} and Prins, \{J M\} and \{van der Meer\}, \{J T M\} and Bonten, \{M J M\} and E Sieswerda and \{van Werkhoven\}, \{C H\} and Sigaloff, \{K C E\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2023.",

year = "2024",

month = feb,

day = "1",

doi = "10.1093/jac/dkad385",

language = "English",

volume = "79",

pages = "476",

journal = "The Journal of antimicrobial chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "2",

}

Buis, DTP, van der Vaart, TW, Prins, JM, van der Meer, JTM, Bonten, MJM, Sieswerda, E, van Werkhoven, CH & Sigaloff, KCE 2024, 'Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)', The Journal of antimicrobial chemotherapy, vol. 79, no. 2, dkad385, pp. 476. https://doi.org/10.1093/jac/dkad385

Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057). / Buis, D T P; van der Vaart, T W; Prins, J M et al.
In: The Journal of antimicrobial chemotherapy, Vol. 79, No. 2, dkad385, 01.02.2024, p. 476.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Correction to:

T2 - Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)

AU - Buis, D T P

AU - van der Vaart, T W

AU - Prins, J M

AU - van der Meer, J T M

AU - Bonten, M J M

AU - Sieswerda, E

AU - van Werkhoven, C H

AU - Sigaloff, K C E

PY - 2024/2/1

Y1 - 2024/2/1

N2 - To our regret we realized that the following error was present in multivariable analyses, neither cefuroxime nor ceftriaxone was the original published version of this article: In the Abstract, associated with increased duration of bacteraemia compared Results section: “In multivariable analyses, neither ceftriaxone with flucloxacillin (HR 1.08, 95% CI 0.73–1.60 and HR 1.22, 95% nor cefuroxime was associated with increased duration of CI 0.88–1.71)”. bacteraemia compared with flucloxacillin (HR 1.08, 95% CI The overall conclusions of the study remain unaltered. 0.73–1.60 and HR 1.22, 95% CI 0.88–1.71)” should read “In We apologize for the inconvenience.

AB - To our regret we realized that the following error was present in multivariable analyses, neither cefuroxime nor ceftriaxone was the original published version of this article: In the Abstract, associated with increased duration of bacteraemia compared Results section: “In multivariable analyses, neither ceftriaxone with flucloxacillin (HR 1.08, 95% CI 0.73–1.60 and HR 1.22, 95% nor cefuroxime was associated with increased duration of CI 0.88–1.71)”. bacteraemia compared with flucloxacillin (HR 1.08, 95% CI The overall conclusions of the study remain unaltered. 0.73–1.60 and HR 1.22, 95% CI 0.88–1.71)” should read “In We apologize for the inconvenience.

UR - https://www.scopus.com/pages/publications/85184136924

U2 - 10.1093/jac/dkad385

DO - 10.1093/jac/dkad385

M3 - Comment/Letter to the editor

C2 - 38078830

SN - 0305-7453

VL - 79

SP - 476

JO - The Journal of antimicrobial chemotherapy

JF - The Journal of antimicrobial chemotherapy

IS - 2

M1 - dkad385

ER -

Buis DTP, van der Vaart TW, Prins JM, van der Meer JTM, Bonten MJM, Sieswerda E et al. Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057). The Journal of antimicrobial chemotherapy. 2024 Feb 1;79(2):476. dkad385. Epub 2023 Dec 11. doi: 10.1093/jac/dkad385

Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)

Abstract

Access to Document

Other files and links

Fingerprint

Research output

Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study

Cite this